Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). Clinical laboratories can process thousands of samples each day for less than $10 per sample … Continue reading Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel